ArticleTranslational psychiatry2018

Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors.

Gaurav Bedse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.